武警医学2011，Vol.22Issue(5)：379-380,2.
依达拉奉联合巴曲酶治疗急性脑梗死疗效观察
Efficacy of edaravone combined with batroxobin in treatment of patients with acute cerebral infarction
刘向东 1孙占超1
作者信息
- 1. 024005,内蒙古赤峰市松山医院神经内科
- 折叠
摘要
Abstract
Objective To investigate the efficacy of edaravone combined with batroxoin in treatment of patients with acute cerebral infarction (ACI). Methods Sixty-five ACI patients within 6 hours of onset were enrolled. They were randomly divided into study group (34 cases) and control group (31 cases). The former received edaravone 30 mg, bid, for 14 days and batroxobin 10, 5,5U qod while the latter was administrated with only batroxobin 10, 5, 5 U qod. The therapeutic effect was evaluated by the National Institutes of Health Stroke Scale (NIHSS) and the Bathal index (BI). Results 1, 2, 3 weeks after treatment, NIHSS was significantly different ( P ＜ 0.05 ) between the study group and the control group, so were the data of BI. Conculsions Edaravone combined with batroxobin is an effective and safe therapy for ACI patients.关键词
急性脑梗死/依达拉奉/巴曲酶/疗效Key words
acute cerebral infarction/ edaravone/ batroxobin/ efficacy分类
临床医学引用本文复制引用
刘向东,孙占超..依达拉奉联合巴曲酶治疗急性脑梗死疗效观察[J].武警医学,2011,22(5):379-380,2.
